CLINICAL_TRIALS
trial_result
· 2012-04-02
Clinical Trial Update: Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis [Phase 2]
Summary
Phase 2 trial evaluating low-dose decitabine for symptomatic myelofibrosis was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Chronic Myeloproliferative Disorders, Secondary Myelofibrosis | Phase 2 | Status: TERMINATED | Results posted: 2012-04-02